CIZZLE BIOTECHNOLOGY HOLDINGS PLC
CIZ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNG2VN02
- LEI:
- 213800G3OS3SA2J1Y358
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://cizzlebiotechnology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cizzle Biotechnology Holdings PLC is a diagnostics development company specializing in the early detection of lung cancer. Originating as a spin-out from the University of York, the firm is advancing a non-invasive blood test that utilizes its proprietary CIZ1B biomarker. The immunoassay is designed to identify lung cancer in its earliest stages with high sensitivity, offering a cost-effective alternative to traditional screening methods like CT scans. By aiming to reduce false positives and the need for subsequent invasive procedures, the test seeks to streamline the cancer care pathway. Cizzle's primary objective is to provide an accessible and accurate diagnostic tool for healthcare professionals and patients worldwide, with the product currently progressing through global clinical trials and regulatory approval processes.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for CIZZLE BIOTECHNOLOGY HOLDINGS PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-18 08:00 |
Regulatory News Service
Commercial Progress in USA
|
English | 22.0 KB | |
| 2025-07-08 10:40 |
Annual Report
Annual Report for the year ended 31 December 2024
|
English | 332.7 KB | |
| 2025-06-06 12:00 |
Report Publication Announcement
Notice of AGM
|
English | 11.4 KB | |
| 2025-05-28 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.1 KB | |
| 2025-03-25 08:00 |
Board/Management Information
Appointment of Non-Executive Director
|
English | 15.7 KB | |
| 2025-01-02 08:00 |
Board/Management Information
Appointment of Professor Dawn Coverley as CSO
|
English | 17.8 KB | |
| 2024-12-16 08:00 |
M&A Activity
Update on Strategic Partnership in North America
|
English | 23.8 KB | |
| 2024-10-21 08:00 |
M&A Activity
Execution of Agreement for North America
|
English | 25.9 KB | |
| 2024-10-03 14:12 |
Regulatory News Service
Update on Licensing and Partnership Agreement
|
English | 10.6 KB | |
| 2024-09-30 08:00 |
Interim Report
Interim Results
|
English | 208.3 KB | |
| 2024-09-16 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 37.5 KB | |
| 2024-09-09 08:00 |
Regulatory News Service
Collaboration with Moffitt Cancer Center
|
English | 25.0 KB | |
| 2024-07-25 08:00 |
Business and Financial Review
Update on Strategic Partnership in North America
|
English | 15.2 KB | |
| 2024-07-18 08:00 |
M&A Activity
Manufacturing Agreement with BBI Solutions
|
English | 21.1 KB | |
| 2024-07-09 08:00 |
Remuneration Information
Issue of Share Options in Lieu of Consultancy Fees
|
English | 14.0 KB |
Automate Your Workflow. Get a real-time feed of all CIZZLE BIOTECHNOLOGY HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
